GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Tian An Medicare 383.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

0.79

-7.10%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in HKD, from our data supplier.

FY2024

Revenue

HK$1.63bn

FY2015FY2024

Net income

HK$28.8m

FY2015FY2024

Free cash flow

−HK$86.9m

FY2015FY2024

Shareholders' equity

HK$1.82bn

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
RevenueHK$1.63bnHK$1.57bnHK$1.44bnHK$1.46bnHK$1.19bnHK$1.84bnHK$1.20bnHK$1.10bnHK$1.28bnHK$2.40bn
Gross profitHK$336.2mHK$290.3mHK$265.6mHK$267.5mHK$220.7mHK$361.7mHK$245.8mHK$173.3mHK$280.4mHK$136.7m
Operating incomeHK$99.7mHK$70.3m−HK$24.9m−HK$11.7mHK$4.2mHK$22.9mHK$16.2m−HK$62.6mHK$94.4m−HK$79.5m
Net incomeHK$28.8mHK$14.7m−HK$123.6m−HK$137.3m−HK$111.9mHK$2.2mHK$34.9m−HK$137.1m−HK$71.8m−HK$783.2m
Diluted earnings per share0.030.02-0.17-0.19-0.150.000.00-0.01-0.01-0.06

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assetsHK$3.54bnHK$3.54bnHK$3.23bnHK$3.49bnHK$3.43bnHK$3.30bnHK$3.33bnHK$3.49bnHK$4.73bnHK$5.95bn
Cash and short-term investmentsHK$890.4mHK$896.9mHK$601.1mHK$596.0mHK$642.8mHK$684.4mHK$488.1mHK$705.5mHK$1.69bnHK$2.01bn
Total liabilitiesHK$1.72bnHK$1.73bnHK$1.68bnHK$1.79bnHK$1.64bnHK$1.50bnHK$1.51bnHK$1.70bnHK$2.77bnHK$3.95bn
DebtHK$836.2mHK$798.6mHK$979.0mHK$972.0mHK$973.9mHK$798.8mHK$825.0mHK$845.2mHK$1.85bnHK$2.67bn
Shareholders' equityHK$1.82bnHK$1.81bnHK$1.55bnHK$1.70bnHK$1.79bnHK$1.80bnHK$1.82bnHK$1.80bnHK$1.96bnHK$1.99bn
Shares outstanding1,086m924m732m732m732m14,480m14,480m14,480m14,480m12,625m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operationsHK$106.0mHK$356.1mHK$70.4mHK$219.4m−HK$15.2mHK$264.6m−HK$50.7mHK$973.4mHK$184.2m—
Capital spending−HK$192.9m−HK$198.0m−HK$138.0m−HK$154.5m−HK$100.5m−HK$143.5m−HK$44.4m−HK$60.0m−HK$124.0m—
Free cash flow−HK$86.9mHK$158.0m−HK$67.5mHK$65.0m−HK$115.7mHK$121.0m−HK$95.1mHK$913.3mHK$60.1m—
Dividends paid−HK$10.9m—————————

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
RevenueHK$783.1mHK$805.7mHK$821.5mHK$807.9mHK$761.0mHK$701.8mHK$736.0mHK$754.8m
Gross profitHK$158.6mHK$153.2mHK$183.0mHK$140.8mHK$149.6mHK$148.1mHK$117.5mHK$130.9m
Operating incomeHK$39.6mHK$38.3mHK$61.5mHK$38.6mHK$31.7m−HK$24.4m−HK$425,000HK$83.8m
Net incomeHK$12.0mHK$7.1mHK$21.7mHK$13.4mHK$1.3m−HK$79.7m−HK$43.9m−HK$63.4m
Diluted earnings per share0.010.010.020.010.00-0.11-0.06-0.09
Total assetsHK$3.44bnHK$3.54bnHK$3.48bnHK$3.54bnHK$3.44bnHK$3.23bnHK$3.34bnHK$3.49bn
Cash and short-term investmentsHK$818.1mHK$890.4mHK$837.0mHK$896.9mHK$830.0mHK$601.1mHK$558.2mHK$596.0m
DebtHK$448.7mHK$443.8mHK$559.4mHK$482.7mHK$305.1mHK$428.2mHK$322.7mHK$365.6m
Shareholders' equityHK$1.82bnHK$1.82bnHK$1.82bnHK$1.81bnHK$1.85bnHK$1.55bnHK$1.63bnHK$1.70bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue3.6%-2.4%8.6%
Operating income—34.2%—
Net income—67.6%-18.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin19.6%19.0%19.1%16.7%
Operating margin5.3%2.2%1.8%0.4%
Net margin1.4%-3.6%-3.6%-6.7%

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Price to earnings27.650.4-6.5-7.4-15.3——-443.6-1572.8-177.3
Price to sales0.50.50.60.71.424.548.055.387.957.9

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 23 May 2025.

FY2025FY2024FY2015FY2012FY2010FY2008FY2007FY2006
Paid in the year0.020.010.050.040.040.040.050.05
  • 20-to-1 reverse split · 24 Feb 2023
  • 20-for-1 split · 15 Jun 2015
  • 1-to-1 reverse split · 10 Aug 2004
  • 25-to-1 reverse split · 15 Jul 2003
  • 10-for-1 split · 30 Jul 1999

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.